See All Slides - tctmd.com

Slides

Presentation TCT 2013

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

Presenter: Peter Wenaweser

October 31, 2013

Presentation TCT 2013

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Presenter: Erwin Blessing

October 31, 2013

Presentation TCT 2013

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

FFR in Patients with Previous Noninvasive Tests: How Do I Integrate Invasive and Noninvasive Assessment of Ischemia?

Presenter: Morton Kern

October 30, 2013

Presentation TCT 2013

Neoatherosclerosis: Clinical Implications (with Case Vignettes)

Presenter: Giora Weisz

October 30, 2013

Presentation TCT 2013

Association of CIN with Adverse Long-term Outcomes: Causal or Confounder? Insights from the VA Database

Presenter: Jeremiah Brown

October 30, 2013

Presentation TCT 2013

A "Presidential" Address

Presenter: David Holmes Jr

October 30, 2013

Presentation TCT 2013

Status Update on the Development of OPCs for Routine DES Approval

Presenter: Laura Mauri

October 30, 2013

Presentation TCT 2013

Off-Site Cath Lab Development

Presenter: Adhir Shroff

October 30, 2013

Presentation TCT 2013

A Randomized Trial of Single Bolus Regadenoson Injection Versus Intravenous Adenosine Infusion of to Induce Maximum Coronary Hyperemia

Presenter: Lokien van Nunen

October 30, 2013

Advertisement

Slides

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

FFR in Patients with Previous Noninvasive Tests: How Do I Integrate Invasive and Noninvasive Assessment of Ischemia?

Neoatherosclerosis: Clinical Implications (with Case Vignettes)

Association of CIN with Adverse Long-term Outcomes: Causal or Confounder? Insights from the VA Database

A "Presidential" Address

Status Update on the Development of OPCs for Routine DES Approval

Off-Site Cath Lab Development

A Randomized Trial of Single Bolus Regadenoson Injection Versus Intravenous Adenosine Infusion of to Induce Maximum Coronary Hyperemia

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content